Wei Zhang

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Epithelial Mesenchymal Transition

Signaling Pathway

Top Venues

Disease markers

This page only lists publications with an associated author ORCID identifier.

Publications

Meng Li, Wenqi Zhang, Yihan Wang, Kai Huang, Tao Sun, Zhicong Qiu, Linqi Yang, Meng Wu, Xiaolu Zhang, Wei Zhang
DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway. Disease markers 2022 (2022)
Meng Li, Wenqi Zhang, Linqi Yang, Huibing Wang, Yihan Wang, Kai Huang, Wei Zhang
The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway. Disease markers 2021 (2021)
Pingping Chen, Huibing Wang, Meng Li, Linqi Yang, Feifei Mou, Bhupinder Singh, Jing-Yu He, Wei Zhang
6,12-Diphenyl-3, 9-diazatetraasterane-1, 5, 7, 11-tetracarboxylate Inhibits Proliferation, Migration and Promotes Apoptosis in Ovarian Cancer Cells. Disease markers 2020 (2020)